Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status.
Ontology highlight
ABSTRACT: Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated via PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes
SUBMITTER: Lems CM
PROVIDER: S-EPMC10449452 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA